Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages


This content is available also in other languages

May 5, 2015 | Customer News

HP D300 Digital Dispenser now offers aqueous liquid dispensing

May 5, 2015

HP D300 Digital Dispenser now offers aqueous liquid dispensing

HP D300 now offers dispensing of DMSO or aqueous solutions for drug discovery workflows

Männedorf, Switzerland, May 5, 2015 – The popular HP D300 Digital Dispenser – available from Tecan – now allows customers to titrate low volumes of biomolecules in aqueous solutions, offering greater flexibility for drug discovery workflows. Users can choose between dispensing DMSO, for small molecule studies, and aqueous solutions in combination with a surfactant, for the investigation of proteins, antibodies, enzymes and nucleic acids.

Newly launched T8+ and D4+ Dispenseheads*, combined with updated software, allow both new and existing customers to benefit from this breakthrough, offering straightforward set-up of dose-response curves and synergy studies. New ‘fluid class’ options allow users to optimize liquid dispensing performance to their specific buffers and surfactants, and an Enzyme Profile function enables fast and easy set-up of titrations using differing combinations of enzymes, substrates and other compounds. These innovative features, combined with the system’s proven low volume dispensing performance, make it easy to perform complex experiments – such as enzyme characterization, Km determination and exploring the effects of enzyme inhibitors – ensuring a comprehensive solution for drug discovery applications.

To find out more about the updated HP D300, visit www.tecan.com/digitaltitration

* For research use only. Not for clinical diagnostics.



For more information please contact

Tecan Trading AG
Antonietta Allocca
Seestrasse 103
CH-8708 Männedorf

Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12



About Tecan

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2014, Tecan generated sales of CHF 400 million (USD 437 million; EUR 331 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).